Biblio

Export 1161 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
1
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., “11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.”, J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., “11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.”, J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., “11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.”, J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
H. Jin Kim, Cho, H., Werring, D. J., Jang, Y. Kyoung, Kim, Y. Jin, San Lee, J., Lee, J., Jun, S., Park, S., Ryu, Y. Hoon, Choi, J. Yong, Cho, Y. Seok, Moon, S. Hwan, Na, D. L., Lyoo, C. Hyoung, and Seo, S. Won, “18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 3, pp. 711-716, 2017.
M. Khosravi, Peter, J., Wintering, N. A., Serruya, M., Shamchi, S. Pourhassan, Werner, T. J., Alavi, A., and Newberg, A. B., “18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
M. Khosravi, Peter, J., Wintering, N. A., Serruya, M., Shamchi, S. Pourhassan, Werner, T. J., Alavi, A., and Newberg, A. B., “18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
H. - L. Gao, Li, C., Nabeka, H., Shimokawa, T., Wang, Z. - Y., Cao, Y. - M., and Matsuda, S., “An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1173-92, 2016.
J. Jia, Zhang, Y., Shi, Y., Yin, X., Wang, S., Li, Y., Zhao, T., Liu, W., Zhou, A., and Jia, L., “A 19-Year-Old Adolescent with Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 915-922, 2023.
2
S. M. de la Monte, Tong, M., and Wands, J. R., “The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1381-1390, 2018.
4
T. Tian, Qin, X., Wang, Y., Shi, Y., and Yang, X., “40 Hz Light Flicker Promotes Learning and Memory via Long Term Depression in Wild-Type Mice.”, J Alzheimers Dis, vol. 84, no. 3, pp. 983-993, 2021.
5
L. Chen, Shen, Q., Xu, S., Yu, H., Pei, S., Zhang, Y., He, X., Wang, Q. Z., and Li, D., “5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.
9
R. Guo, Fan, G., Zhang, J., Wu, C., Du, Y., Ye, H., Li, Z., Wang, L., Zhang, Z., Zhang, L., Zhao, Y., and Lu, Z., “A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1365-1377, 2017.
R. Guo, Fan, G., Zhang, J., Wu, C., Du, Y., Ye, H., Li, Z., Wang, L., Zhang, Z., Zhang, L., Zhao, Y., and Lu, Z., “A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1365-1377, 2017.
A
C. D. Pereira, Martins, F., Wiltfang, J., Silva, O. A. B. da Cru, and Rebelo, S., “ABC Transporters Are Key Players in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 463-485, 2018.
Q. - F. Zhao, Wan, Y., Wang, H. - F., Sun, F. - R., Hao, X. - K., Tan, M. - S., Tan, C. - C., Zhang, D. - Q., Tan, L., and Yu, J. - T., “ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.”, J Alzheimers Dis, vol. 52, no. 2, pp. 693-703, 2016.
Q. - F. Zhao, Wan, Y., Wang, H. - F., Sun, F. - R., Hao, X. - K., Tan, M. - S., Tan, C. - C., Zhang, D. - Q., Tan, L., and Yu, J. - T., “ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.”, J Alzheimers Dis, vol. 52, no. 2, pp. 693-703, 2016.
L. Ni, Liu, R., Yin, Z., Zhao, H., Nedelska, Z., Hort, J., Zhou, F., Wu, W., Zhang, X., Li, M., Yu, H., Zhu, B., Xu, Y., and Zhang, B., “Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and concomitant Lacunar Infarction: A Resting-State Functional MRI Study.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1243-54, 2016.
B. Wang, Miao, L., Niu, Y., Cao, R., Li, D., Yan, P., Guo, H., Yan, T., Wu, J., and Xiang, J., “Abnormal Functional Brain Networks in Mild Cognitive Impairment and Alzheimer's Disease: A Minimum Spanning Tree Analysis.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1093-1107, 2018.
B. Wang, Miao, L., Niu, Y., Cao, R., Li, D., Yan, P., Guo, H., Yan, T., Wu, J., and Xiang, J., “Abnormal Functional Brain Networks in Mild Cognitive Impairment and Alzheimer's Disease: A Minimum Spanning Tree Analysis.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1093-1107, 2018.
N. L. Spartano, Himali, J. J., Trinquart, L., Yang, Q., Weinstein, G., Satizabal, C. L., Dukes, K. A., Beiser, A. S., Murabito, J. M., Vasan, R. S., and Seshadri, S., “Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 85, no. 2, pp. 805-814, 2021.
M. K. Lupton, Medland, S. E., Gordon, S. D., Goncalves, T., MacGregor, S., Mackey, D. A., Young, T. L., Duffy, D. L., Visscher, P. M., Wray, N. R., Nyholt, D. R., Bain, L., Ferreira, M. A., Henders, A. K., Wallace, L., Montgomery, G. W., Wright, M. J., and Martin, N. G., “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
M. K. Lupton, Medland, S. E., Gordon, S. D., Goncalves, T., MacGregor, S., Mackey, D. A., Young, T. L., Duffy, D. L., Visscher, P. M., Wray, N. R., Nyholt, D. R., Bain, L., Ferreira, M. A., Henders, A. K., Wallace, L., Montgomery, G. W., Wright, M. J., and Martin, N. G., “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
M. K. Lupton, Medland, S. E., Gordon, S. D., Goncalves, T., MacGregor, S., Mackey, D. A., Young, T. L., Duffy, D. L., Visscher, P. M., Wray, N. R., Nyholt, D. R., Bain, L., Ferreira, M. A., Henders, A. K., Wallace, L., Montgomery, G. W., Wright, M. J., and Martin, N. G., “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., “Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.”, J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
T. C. Durazzo, Korecka, M., Trojanowski, J. Q., Weiner, M. W., Hara, R. O. ', Ashford, J. W., and Shaw, L. M., “Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.”, J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.

Pages